Ultrasound guided Pericapsular nerve group block vs. Suprainguinal fascia iliaca compartment block in paediatric hip surgery

Phase 3

Not yet recruiting

• Conditions: Congenital deformity of hip, unspecified,

• Registration Number: CTRI/2025/05/087962
• Lead Sponsor: Rakesh kumar

Brief Summary

**Comparison of Ultrasound Guided Pericapsular Nerve Group (PENG) Block Versus Suprainguinal Fascia Iliaca Compartment Block (SIFICB) in Paediatric Patients Undergoing Hip Surgery: A Randomised Controlled Trial** is a prospective, doubleblind, randomised controlled study conducted by Dr. Rakesh Kumar at PGIMER, Chandigarh. The study is scheduled from March 2025 to May 2026 and will include 60 pediatric patients aged 18 months to 12 years, classified as ASA physical status I or II, who are scheduled for elective hip surgery. The primary aim of the study is to compare the analgesic efficacy of PENG block and SIFICB by evaluating postoperative pain scores using the FLACC or VAS scale at 24 hours. Secondary objectives include assessing intraoperative and postoperative opioid consumption, time to first rescue analgesia, duration of stay in the post-anesthesia care unit (PACU), total 24 hour analgesic use, functional recovery, and complications related to the block procedures.

All patients will undergo general anesthesia and receive either a PENG block or SIFICB using ultrasound guidance with 0.2% ropivacaine (0.4 ml/kg, maximum 2 mg/kg). Pain will be assessed at multiple intervals using FLACC scores for children under 7 and VAS scores for older children. Rescue analgesia with fentanyl, acetaminophen, or ketorolac will be administered as needed. Intraoperative hemodynamics and block effectiveness will also be monitored. Randomization will be achieved through computer-generated numbers and allocation concealment with sealed envelopes. Blinding will be maintained for the anaesthetist assessing outcomes and the surgical team.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-05-22
• Study Start: 2025-09-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Asa 1 ans 2.

Exclusion Criteria

Any history of allergic to any drugs, presence of a congenital heart disease,any renal ,hepatic disease, asa 3 and 4 , local infection and coagulopathy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare pain between PENG and SIFICB groups using pain score ( FLACC,VAS)	POSTOPERATIVE 24 HRS

Secondary Outcome Measures

Name	Time	Method
Intraoperative and postoperative opioid consumption
Total 24 hr of analgesia consumption
Postoperative pain assessment	0,4,8,12,24 hrs
To assess functional recovery ,
Time to first rescue analgesia
Duration of PACU stay

Trial Locations

Locations (1)

OT , HOSPITAL; 🇮🇳 Chandigarh, CHANDIGARH, India

OT , HOSPITAL

🇮🇳Chandigarh, CHANDIGARH, India

Dr RAKESH KUMAR

Principal investigator

9812371711

Rakeshnehra73@gmail.com